These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30147087)

  • 1. Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit.
    Khattry N; Laskar S; Sengar M; Rangarajan V; Shet T; Subramanian PG; Epari S; Bagal B; Goda JS; Agarwal A; Jain H; Tembhare P; Patkar N; Khanna N; Punatar S; Gokarn A; Shetty D; Jain H; Bonda A; Gota V; Hasan S; Kode J; Dutt S; Kulkarni S; Shetty N; Sable N; Deodhar J; Jadhav S; Pawaskar P; Mathew L; Menon H; Nair R; Kannan S; Chiplunkar S; Gujral S
    Indian J Cancer; 2018; 55(1):9-15. PubMed ID: 30147087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital.
    Narula G; Prasad M; Jatia S; Subramanian PG; Patkar N; Tembhare P; Shetty D; Khanna N; Laskar S; Shet T; Epari S; Kembhavi S; Shah S; Qureshi S; Gujral S; Banavali SD
    Indian J Cancer; 2017; 54(4):609-615. PubMed ID: 30082544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
    Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
    Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 14-year retrospective analysis of indications and outcomes of autologous haemopoietic stem cell transplantation in regional Queensland: a single-centre experience.
    Hamilton EM; Nath KD; Vangaveti VN; McCutchan AD; Marsh JL; Birchley AJ; Casey JM; McNamara C; Lai HC; Morris ES; Hodges G; Irving IM
    Intern Med J; 2020 Feb; 50(2):214-221. PubMed ID: 32037713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.
    McCarthy PL; Hahn T; Hassebroek A; Bredeson C; Gajewski J; Hale G; Isola L; Lazarus HM; Lee SJ; Lemaistre CF; Loberiza F; Maziarz RT; Rizzo JD; Joffe S; Parsons S; Majhail NS
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1116-23. PubMed ID: 23660172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.
    Kusnierz-Glaz CR; Schlegel PG; Wong RM; Schriber JR; Chao NJ; Amylon MD; Hu WW; Negrin RS; Lee Y; Blume KG; Long GD
    J Clin Oncol; 1997 Jan; 15(1):18-25. PubMed ID: 8996120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies -- three years' follow-up.
    Sykorova A; Horacek J; Zak P; Kmonicek M; Bukac J; Maly J
    Neoplasma; 2005; 52(6):476-82. PubMed ID: 16284692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country.
    Ali N; Adil SN; Shaikh MU
    Stem Cells Transl Med; 2015 Aug; 4(8):873-7. PubMed ID: 26032748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
    Ke X; Yang Y; Zhao X; Wang L
    Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eight years of experience in a single institution in hematopoietic stem cell autologous transplantation in malignant hematological diseases and in solid tumors].
    Milone GA; Martínez Rolón J; Fernández II; Corrado CS; Desmery PM; Dignani MC; Juni M; Pavlovsky S
    Medicina (B Aires); 2000; 60(1):115-24. PubMed ID: 10835708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
    Leak SA; Mmbaga LG; Mkwizu EW; Mapendo PJ; Henke O
    PLoS One; 2020; 15(5):e0232848. PubMed ID: 32374771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.
    Gupta A; Gokarn A; Rajamanickam D; Punatar S; Thippeswamy R; Mathew L; Bagal B; Kannan S; Khattry N
    J Cancer Res Ther; 2018; 14(5):926-933. PubMed ID: 30197327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.
    Persoon S; Kersten MJ; Chinapaw MJ; Buffart LM; Burghout H; Schep G; Brug J; Nollet F
    BMC Cancer; 2010 Dec; 10():671. PubMed ID: 21134270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous transplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I: patients].
    Medinger P; Tissot JD; Nicoloso de Faveri G; Kovacsovics TJ; Perey L; Schneider P; Zwicky C
    Schweiz Med Wochenschr; 2000 Apr; 130(13):478-84. PubMed ID: 10812643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Majolino I; Pearce R; Taghipour G; Goldstone AH
    J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma.
    Gordan LN; Sugrue MW; Lynch JW; Williams KD; Khan SA; Moreb JS
    Bone Marrow Transplant; 2003 Jun; 31(11):1009-13. PubMed ID: 12774052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.